TUTELA TUT-001A

A Prospective, First-In-Human, Single Arm Study to Evaluate the SafeTy, Dosimetry, and Clinical Effects of a Perirectal Thermoresponsive Spacer Device in Patients Undergoing CuraTive Intent ProstatE Modulated Radiotherapy (TUTELA)

Enquire

Trial overview

Clinical Area

Radiation Oncology

Disease

Prostate cancer

Disease site

Genitourinary (GU)

Study Phase

Trial Identifiers

Registration number: ACTRN12624001348549

https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=388485

GenesisCare Location(s)

Ringwood (Ringwood Private Hospital)

Ringwood Private Hospital, 36 Mount Dandenong Road, Ringwood East, VIC, 3135, Australia

(03) 8870 3300

ringwoodreception@genesiscare.com

Find out more Get directions

Principal Investigator(s)

Radiation Oncologist

Prof Michael Chao

MBBS (Hons) FRANZCR AFRACMA DMedSc

View Profile

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.

First name *

Last name *

Email *

Phone *

State *

Postcode *

What is the reason for enquiry?

How would you prefer to be contacted? *

Phone

By submitting you acknowledge we will use the information you are providing to contact you about your enquiry. For more information about how we handle your personal information, please refer to the GenesisCare Privacy Policy.

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.

Disclaimer: